Table 3. Subgroup analysis relation to rapidly objective response.
| Patient | ECOG PS | DOSAGE(mg) | WBC (/mm3) | SAAG(g/dl) | rOR | OR |
|---|---|---|---|---|---|---|
| 01 | 2 | 50 | 10600 | -- | O | O |
| 02 | 2 | 50 | 9200 | -- | X | O |
| 03 | 2 | 50 | 2500 | -- | O | O |
| 04 | 2 | 50 | 4800 | -- | X | O |
| 05 | 3 | 100 | 10400 | -- | X | X |
| 06 | 3 | 100 | 37200 | 1.72 | X | X |
| 07 | 2 | 100 | 4760 | 1.05 | X | O |
| 08 | 2 | 50 | 7870 | 0.67 | O | O |
| 09 | 2 | 100 | 9400 | 1.12 | X | X |
| 10 | 2 | 100 | 6380 | 0.48 | O | O |
| 11 | 2 | 50 | 4600 | 1.02 | X | O |
| 12 | 2 | 100 | 3100 | 1.96 | X | O |
| 13 | 2 | 50 | 5580 | 0.72 | O | O |
| 14 | 2 | 50 | 5900 | 0.8 | O | O |
| 15 | 3 | 50 | 2300 | 1.3 | X | X |
Abbreviations: O: yes; X: no; ECOG: Eastern Cooperative Oncology Group performance status; OR: objective response; rOR: rapidly objective response; SAAG: serum ascites albumin gradient; WBC: white blood cell